Modulation of inflammatory response and parasitism by 15-Deoxy-Δ12,14 prostaglandin J2 in Trypanosoma cruzi-infected cardiomyocytes

International Journal for Parasitology

Volumn 41, Issue 5, 2011, Pages 553-562

  Hovsepian, Eugenia ^a   Mirkin, Gerardo A ^b   Penas, Federico ^a   Manzano, Anna ^c   Bartrons, Ramon ^c   Goren, Nora B ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

15 Deoxy 12,14 prostaglandin J2; Erk MAPK; Inflammation; Neonatal cardiomyocytes; NF B; Parasitism; PPAR ; Trypanosoma cruzi

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

CHAGAS DISEASE; ENZYME; GENE EXPRESSION; LIGAND; NEONATE; NITRIC OXIDE; PARASITISM; RNA; RODENT;

ANIMAL CELL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HEART MUSCLE CELL; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; PARASITE CONTROL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; CHAGAS DISEASE; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MALE; MICE; MYOCYTES, CARDIAC; PPAR GAMMA; PROSTAGLANDIN D2; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 79952693649     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.12.002     Document Type: Article

References (28)

1. Aoki M.P., Canoa R.C., Pellegrinia A.V., Tanosb T., Guiñazúa N.L., Cosob O.A., Gea S. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect. 2006, 8(7):1723-1731.
2. Castrillo A., Diaz-Guerra M.J., Hortelano S., Martin-Sanz P., Bosca L. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-Deoxy-Delta(12, 14)-prostaglandin J(2) in activated murine macrophages. Mol. Cell Biol. 2000, 20:1692-1698.
3. Collin M., Patel N.S.A., Dugo L., Thiemermann C. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-Deoxydelta12, 14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit. Care Med. 2004, 32:826-831.
4. Cuenca J., Martin-Sanz P., Alvarez-Barrientos A.M., Bosca L., Goren N. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am. J. Pathol. 2006, 169:1567-1576.
5. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 2002, 81:123-132.
6. Gallardo-Soler A., Gomez-Nieto C., Campo M.L., Marathe C., Tontonoz P., Castrillo A., Corraliza I. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity. Mol. Endocrinol. 2008, 22:1394-1402.
7. Gardner O.S., Dewar B.J., Graves L.M. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol. Pharmacol. 2005, 68:933-941.
8. Gonzalez Cappa S.M., Bijovsky A.T., Freilij H., Muller L., Katzin A.M. Isolation of a Trypanosoma cruzi strain of predominantly slender from Argentina. Medicina (B. Aires) 1981, 41:119-120.
9. Goren N., Cuenca J., Martin-Sanz P., Bosca L. Attenuation of NF-kappaB signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes. Cardiovasc. Res. 2004, 64:289-297.
10. Gutierrez F.R.S., Lalu M.M., Mariano F.S., Milanezi C.M., Cena J., Gerlach R.F., Santos J.E.T., Torres-Duenas D., Cunha F.Q., Schulz R., Silva J.S. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J. Infect. Dis. 2008, 197:1468-1476.
11. Holscher C., Kohler G., Muller U., Mossmann H., Schaub G.A., Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 1998, 66:1208-1215.
12. Hovsepian E., Penas F., Goren N. 15-Deoxy-Delta12, 14 PGJ2 but not rosiglitazone regulates MMP-9, NOS-2 and COX-2 expression and function by PPARgamma-dependent and independent mechanisms in cardiac cells. Shock 2010, 34:60-67.
13. Krishnamurthy P., Rajasingh J., Lambers E., Qin G., Losordo D.W., Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ. Res. 2009, 104:e9-18.
14. Lee J.H., Woo J.H., Woo S.U., Kim K.S., Park S.M., Joe E., Jou I. The 15-Deoxy-Delta 12, 14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. J. Immunol. 2008, 181:8642-8649.
15. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
16. Machado F.S., Souto J.T., Rossi M.A., Esper L., Tanowitz H.B., Aliberti J., Silva J.S. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect. 2008, 10:1558-1566.
17. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzón I.M., Nepomnaschy I., Costa H., Cañones C., Raiden S., Vermeulen M., Geffner J.R. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PloS One 2010, 5:e9252.
18. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simoes M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
19. Massion P.B., Feron O., Dessy C., Balligand J. Nitric oxide and cardiac function: ten years after, and continuing. Circ. Res. 2003, 93:388-398.
20. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 1992, 33:35-40.
21. Qian Z., Gelzer-Bell R., Yang Sx S.X., Cao W., Ohnishi T., Wasowska B.A., Hruban R.H., Rodriguez E.R., Baldwin W.M., Lowenstein C.J. Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection. Circulation 2001, 104:2369-2375.
22. Rodrigues M.M., Ribeirao M., Boscardin S.B. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol. Lett. 2000, 73:43-50.
23. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000, 403:103-108.
24. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., Glass C.K. 15-Deoxy-Delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. USA 2000, 97:4844-4849.
25. Tarleton R.L. Parasite persistence in the etiology of Chagaś disease. Int. J. Parasitol. 2001, 31:550-554.
26. Tarleton R.L. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 2007, 19:430-434.
27. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002, 18:262-265.
28. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 2002, 37:375-536.